Core Thesis - Jefferson Capital, Inc. (JCAP) is viewed negatively due to its underlying unit economics and capital-intensive business model, despite attractive headline metrics [1][8]. Company Overview - Jefferson Capital is a newly public company that specializes in purchasing charged-off consumer debt, with a majority ownership of 67% by J.C. Flowers [2]. - The company targets to buy defaulted loan portfolios at approximately 5–6% of their face value, aiming for a 2x gross recovery multiple through various collection methods [2]. Financial Metrics - JCAP's trailing P/E ratio is reported at 9.26, with shares trading at $22.07 as of February 11th [1]. - The company has achieved a levered free cash flow yield of around 20% and a year-over-year operating income growth of 39% [3]. Unit Economics - Mature vintages from 2017–2020 yielded about 2x gross recoveries and over 27% IRRs before operating costs, but cash operating expenses average around 40% of collections [4]. - After accounting for these costs, implied unlevered returns drop to the high single digits [4]. Valuation Insights - Assuming a 60% after-tax recovery margin, modeled equity values are estimated between $300–400 million, after deducting $1.3–1.4 billion in liabilities, indicating limited upside potential [5]. - Although JCAP appears inexpensive compared to peers like Encore Capital and PRA Group, its capital-intensive model resembles a capital-recycling operation rather than a true compounding business [5]. Reinvestment and Governance - Nearly all excess cash flow must be reinvested to maintain portfolio size, as demonstrated by a $300 million loan book purchase in late 2025 [6]. - Sustainable through-cycle ROEs are likely in the 12–13% range, and governance is tightly controlled by its private equity sponsor, suggesting a valuation closer to book value rather than its current premium [6].

Core Thesis - A bearish thesis on Patria Investments Limited (PAX) highlights significant operational and financial concerns, suggesting the company may be overstating performance and masking losses [1][2][8] Financial Performance - As of February 9th, PAX's share price was $14.57, with trailing and forward P/E ratios of 20.91 and 8.14 respectively [1] - The firm has approximately USD 50 billion in assets under management (AUM) [2] Investment Concerns - Key holdings are distressed and marked at extreme premiums compared to listed peers, including a pharmaceutical distributor valued at 15x EV/EBITDA despite bonds trading near 50 cents on the dollar [3] - Other major investments include a loss-making hospital chain and a struggling renewables platform, marked at multiples significantly above market norms [3] Financial Engineering - Patria appears to sustain performance fees through circular internal transactions, asset shuffling, and questionable exits, such as a water desalination plant moved between its own funds [4] - Fundraising has relied on prepayments to limited partners (LPs) and large anchor commitments from affiliated entities, masking weak third-party demand [4] Governance and Management Issues - Governance concerns are elevated, including a CFO resignation, unexplained auditor change, high employee turnover, and the exit of Blackstone's 40% stake, which removed prior external validation [5] Debt and Dividend Sustainability - The firm's reliance on debt, deferred payments, and synthetic earnings to support AUM growth and share buybacks raises risks regarding dividend sustainability, especially in a high-interest Brazilian macro environment [6] - PAX's valuation appears stretched, with a 3.5% yield offering limited upside relative to the structural and operational risks faced by investors [6]

Core Thesis - Sable Offshore Corp. (SOC) is facing significant regulatory, legal, and financial challenges that cast doubt on its ability to restart pipeline operations in the near term [2][4][5]. Regulatory and Legal Challenges - SOC's Las Flores pipelines have been delayed repeatedly, with no oil flowing as of early 2026, despite initial expectations for a January 2024 restart [2]. - CEO Jim Flores' strategy for a stealth restart has been hindered by complex legal barriers, including federal consent decrees and state injunctions, as well as California SB 237, which mandates new coastal development permits for inactive pipelines [3]. - Federal safety approvals from PHMSA provide limited relief, as state authorities maintain control over essential environmental and coastal approvals [3]. Financial Situation - SOC is experiencing a severe financial crunch, having burned through substantial operating and capital expenditures despite a $250 million equity raise [4]. - Projections have been exceeded, and cash reserves are dwindling, raising concerns about the company's ability to secure additional funding before overcoming regulatory hurdles [4]. - Legal experts indicate that even successful litigation in federal court may not be sufficient to bypass entrenched state restrictions, leaving SOC in a precarious financial position [4]. Investment Outlook - Given the combination of depleted cash, missed deadlines, and challenging approvals, SOC's prospects appear bearish, making it a highly speculative investment with substantial downside risk [5]. - The stock price has depreciated by approximately 74.23% since a previous bullish thesis was published, highlighting the steep challenges facing the company [6].